Resveratrol inhibits the expression of RYR2 and is a potential treatment for pancreatic cancer.
Naunyn Schmiedebergs Arch Pharmacol
; 395(3): 315-324, 2022 03.
Article
in En
| MEDLINE
| ID: mdl-35044499
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Pancreatic Neoplasms
/
Ryanodine Receptor Calcium Release Channel
/
Resveratrol
/
Antineoplastic Agents, Phytogenic
Limits:
Humans
Language:
En
Journal:
Naunyn Schmiedebergs Arch Pharmacol
Year:
2022
Document type:
Article
Affiliation country:
China
Country of publication:
Germany